WHO — All Publications — Chidi Oguamanam

Access to Covid-19 Vaccines: the Patent Freeze Proposal and a New Global Strategy

As the vaccination rate rises in Canada and other developed nations, developing countries globally continue to record an upsurge in daily infection and death rates due to COVID-19. Prime Minister Justin Trudeau recently confirmed that Canada is involved in the World Trade Organization’s (WTO) exploration of the Indian and South African proposal to waive intellectual property (IP) rights for COVID-19 vaccines. In a break from tradition, United States President Joe Biden has lent his country’s support to the initiative, amidst reluctance to do the same from the EU. However, Canada remains ambivalent.

Covid-19 Digital Health Innovations: The African Context

“Dealing with health and economic challenges of Covid-19 has made one point abundantly clear for African countries – that we need broadband, faster, cheaper and expanded to the last mile of the populations”. This observation credited to UN Under Secretary-General and Executive Secretary of the Economic Commission for Africa, Ms. Vera Songwe has never rung truer than in these unprecedented times. Leveraging technology to assist African countries in the fight against Covid-19 is imperative to finding effective solutions for containing the virus in an economically feasible manner for Africa, taking into consideration the continent’s technological infrastructure.

Vaccine certificates should not come at expense of other COVID priorities

On Feb. 21, 2021, Israel introduced “green passes” – evidence of COVID-19 vaccination or presumed immunity after recovery from the disease. This form of certificate is called by several other names, most notably immunity passports. According to the global vaccine alliance GAVI, “an immunity passport is an official document that certifies an individual has been infected and is purportedly immune from SARS CoV-2.”

Africa's Unique Vulnerabilities Require a Different Pandemic Approach

Africa’s fate is precarious in the face of COVID-19. It is the last continent to be affected by COVID-19 following the arrival of the contagion in Egypt and Nigeria in February 2020. Ideally, the late arrival of COVID-19 in Africa could have bought the world’s poorest and politically susceptible continent an advantage. However, a combination of unpreparedness and the severity of COVID-19’s impact left Africa with no such advantage.

Op-EdChidi OguamanamOctober 6, 2020Africa, WHO, COVID-19, Senegal, China, United Nations, Ghana, Nigeria, Kenya, Health Law and Medical Ethics, Education

COVID-19 and Vaccine Nationalism: Africa’s Pathway to Access

Except perhaps South Africa, credible statistics on the extent of the COVID-19 infection in African countries are lacking. So far, African countries could not sustain two full months of lockdown. Unlike the rest of the developed world, there were no significant palliatives for ordinary citizens, let alone businesses or corporations. While industrialised countries compute their GDP contraction arising from COVID-19 in the range of 10%, virtually all of Africa is faced with the stark reality of an upward of 20% drop in their GDP and a total rollback of economic progress of the past two decades.

Op-EdChidi OguamanamOctober 6, 2020Africa, WHO, Vaccine, COVID-19, Canada, R&D, Health Law and Medical Ethics

Expedited COVID-19 R&D: Indigenous Knowledge and ABS Imperative

With the world on edge as the COVID-19 crisis progresses, the scientific community has sprung into gear in search of an effective treatment. R&D is progressing at unprecedented speeds, abridging the projected length for the completion of a vaccine from over a decade to just over a year. Amidst this rapid development, traditional knowledge plays a significant role in scientific endeavours. Through traditional knowledge, medical researchers can gain guidance and inspiration and bypass prolonged and expensive scatter-gun approaches to R&D.

COVID-19: In the Shadow of Ebola, the Patent War to Come and a Forgotten Africa

In the midst of the COVID-19 pandemic, the world continues to overlook the epidemic raging on in some of the poorest regions of Africa since 2013: the Ebola outbreak. The Ebola virus is a severe disease with a death rate of up to 90% in humans. The virus was first identified in 1976 with two simultaneous outbreaks; one in the Yambuku village in the Democratic Republic of the Congo (DRC) and the other in a remote area of Sudan.

ALL PUblications